More than a quarter of patients with renal cell carcinoma on active surveillance experience spontaneous tumor regression, researchers report.
Arizona children with autism risk losing therapy services due to a contract dispute between an insurer and a local autism ...
A dispute between an Arizona Medicaid insurer and a large autism therapy provider could leave hundreds of patients searching ...
Clinical data must be strong enough to exclude regression to the mean.
Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National ...
This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...
News Medical on MSN
Development of therapeutic cancer vaccines based on cancer immunity cycle
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...
Morgan showed the video to her doctor, and following tests, Lydia was diagnosed with Sanfilippo syndrome B — often called ...
Researchers sought to develop and validate artificial neural networks for overall survival and progression-free survival in older adults with HNSCC following definitive chemoradiation.
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...
Dr Mark Kris discusses how a small 2015 study with just two nivolumab doses led to a wave of curative-intent trials.
PRESS RELEASE AI-discovered candidate CHM-029 demonstrates robust, dose-dependent tumor regression in pre-clinical AML models and retains potency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback